← Back to search
GENCYTE THERAPEUTICS INC
SAN CARLOS, CA, 94070
UnclaimedClaim this profile (free)
Small BusinessMinority Owned
Prime contracting experience
2 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Health and Human Services National Institutes of Health | PHASE I SBIR CONCEPT AWARD FOR LOGIC GATED MOLECULAR ADAPTOR SYSTEM FOR JMML TREATMENT | — | $499,990 | Jul 16, 2026 | Sep 12, 2025 – May 31, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | GENCYTE THERAPEUTICS, INC. PROPOSES DEVELOPING A SYNTHETIC NOTCH RECEPTOR (SYNNOTCH) CONTROLLED PRECISION MOLECULAR ADAPTOR (PMA) SYSTEM, NAMEDED SYNNOTCH PMA CAR, FOR JMML TREATMENT. THIS PROPOSED PLATFORM TECHNOLOGY COULD POTENTIALLY LOWER CAR-T TO | — | $354,964 | Jun 11, 2024 | Feb 27, 2023 – Aug 26, 2024 |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Agencies supported
- Department of Health and Human ServicesGov-sourced
Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.